CJRTP

Chinese Journal of Rehabilitation Theory and Practice >

2020 , Vol. 26 >Issue 6: 730 - 737

DOI: https://doi.org/10.3969/j.issn.1006-9771.2020.06.020

Clinical Features of Trousseau's Syndrome with Acute Multiple Cerebral Infarction as the First Manifestation

  • Lin-jia GUO ,
  • Jing CHEN ,
  • Feng-lian GAO ,
  • Yun ZHANG ,
  • Wen-hong LIU
Expand
  • Department of Neurology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China

Received date: 2020-03-28

  Revised date: 2020-04-10

  Online published: 2020-06-29

Fold

Abstract

Objective To investigate the clinical features of Trousseau's syndrome with acute multiple cerebral infarction (AMCI) as the first manifestation.Methods From January, 2012 to January, 2019, a retrospective study was conducted on 19 patients with AMCI diagnosed as the first manifestation of Trousseau's syndrome. The clinical data, imaging features, laboratory results, treatment, and prognosis data were collected and analyzed.Results They were (71.05±10.59) years old, with ten males and nine females. MRI-diffusion weighted imaging (DWI) showed numerous small lesions with or without large area cerebral infarction in multiple vascular territories. Fifteen cases (78.95%) showed bilateral infarction, eleven cases (57.89%) showed multiple small lesions (< 20 mm) in multiple vascular territories, nine cases showed cerebral artery stenosis, in which seven cases (77.78%) of cerebral infarction lesions were not consistent with stenotic vessels. All patients had elevated levels of D-dimer with a median of 3.08 mg/L (0.79~7.00 mg/L). Cardiac troponin I (cTnI) increased in eight cases. CA125 increased in 17 cases. Among the 15 cases treated with antiplatelet therapy, five cases (33.3%) were combined with anticoagulation therapy. Nine cases (47.37%) developed early neurological function deterioration or recurrent cerebral infarction during hospitalization. After the follow-up, five cases died within 30 days, and six recurrent thrombotic events occurred within 90 days, including three events for cerebral infarction and three events for lower limb venous thrombosis, and finally 13 cases (68.42%) died within 90 days.Conclusion AMCI can be the first manifestation of Trousseau's syndrome. The image features including bilateral small infarction or multiple lesions being not consistent with the stenotic vessels, combined with the elevated levels of D-dimer, cTnI and CA125, can be the clues to Trousseau's syndrome caused by hypercoagulability due to cancer. Timely screening for occult cancer and active anticancer therapy may be helpful to improve their outcome.

Key words： Trousseau's syndrome; cerebral infarction; cancer; hypercoagulability; troponin

Cite this article

Lin-jia GUO , Jing CHEN , Feng-lian GAO , Yun ZHANG , Wen-hong LIU . Clinical Features of Trousseau's Syndrome with Acute Multiple Cerebral Infarction as the First Manifestation[J]. Chinese Journal of Rehabilitation Theory and Practice, 2020 , 26(6) : 730 -737 . DOI: 10.3969/j.issn.1006-9771.2020.06.020

References

[1] Trousseau A. Plegmasia alba dolens. Lectures on clinical medicine[C]. Paris, 1865:281-332.
[2] Varki A. Trousseau's syndrome: multiple definitions and multiple mechanisms[J]. Blood, 2007, 110(6):1723-1729.
[3] Ikushima S, Ono R, Fukuda K, et al. Trousseau's syndrome: cancer-associated thrombosis[J]. Jpn J Clin Oncol, 2016, 46(3):204-208.
[4] Blom J W, Doggen C J, Osanto S, et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis[J]. JAMA, 2005, 293(6):715-722.
[5] Grilz E, Konigsbrugge O, Posch F, et al. Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer[J]. Haematologica, 2018, 103(9):1549-1556.
[6] Navi B B, Iadecola C. Ischemic stroke in cancer patients: a review of an underappreciated pathology[J]. Ann Neurol, 2018, 83(5):873-883.
[7] Navi B B, Reiner A S, Kamel H, et al. Arterial thromboembolic events preceding the diagnosis of cancer in older persons[J]. Blood, 2019, 133(8):781-789.
[8] De Stefano V. Arterial thrombosis and cancer: the neglected side of the coin of Trousseau syndrome[J]. Haematologica, 2018, 103(9):1419-1421.
[9] Schwarzbach C J, Fatar M, Eisele P, et al. DWI lesion patterns in cancer-related stroke: specifying the phenotype[J]. Cerebrovasc Dis Extra, 2015, 5(3):139-145.
[10] Taccone F S, Jeangette S M, Blecic S A. First-ever stroke as initial presentation of systemic cancer[J]. J Stroke Cerebrovasc Dis, 2008, 17(4):169-174.
[11] Kim S J, Park J H, Lee M J, et al. Clues to occult cancer in patients with ischemic stroke[J]. PLoS One, 2012, 7(9):e44959.
[12] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(9):666-682.
[13] Kwon H M, Lee Y S, Bae H J, et al. Homocysteine as a predictor of early neurological deterioration in acute ischemic stroke[J]. Stroke, 2014, 45(3):871-873.
[14] Mai H, Xia J, Wu Y, et al. Clinical presentation and imaging characteristics of occult lung cancer associated ischemic stroke[J]. J Clin Neurosci, 2015, 22(2):296-302.
[15] Barnett H, Taylor D W, Haynes R B, et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis[J]. N Engl J Med, 1991, 325(7):445-453.
[16] Bang O Y, Chung J, Lee M J, et al. Cancer-related stroke: an emerging subtype of ischemic stroke with unique pathomechanisms[J]. J Stroke, 2020, 22(1):1-10.
[17] 郭琳佳, 虞峰, 陈靖, 等. 恶性肿瘤与非肿瘤患者发生脑梗死的临床与影像特点比较[J]. 中国康复理论与实践, 2018, 24(11):1338-1343.
[18] Zuo P Y, Chen X L, Liu Y W, et al. Increased risk of cerebrovascular events in patients with cancer treated with bevacizumab: a meta-analysis[J]. PLoS One, 2014, 9(7):e102484.
[19] Li S H, Chen W H, Tang Y, et al. Incidence of ischemic stroke post-chemotherapy: a retrospective review of 10,963 patients[J]. Clin Neurol Neurosurg, 2006, 108(2):150-156.
[20] 张晓, 赵媛, 李尧, 等. 以急性多发性脑梗死为表现的Trousseau综合征的临床特征研究[J]. 实用心脑肺血管病杂志, 2018, 26(8):37-42.
[21] 黄刚, 袁敏, 项正兵, 等. 以多发性急性脑梗死为表现的Trousseau综合征临床及影像学特点分析[J]. 中风与神经疾病杂志, 2017, 34(9):797-800.
[22] 国丽茹, 李彦青, 王澜涛, 等. 以多发急性脑梗死为首发表现的Trousseau综合征12例临床分析[J]. 中华全科医师杂志, 2019, 18(5):479-482.
[23] 张璇, 郭文静, 陈菲, 等. Trousseau综合征引起的缺血性脑卒中2例并文献复习[J]. 神经损伤与功能重建, 2019, 14(1):40-42, 52.
[24] Sanossian N, Djabiras C, Mack W J, et al. Trends in cancer diagnoses among inpatients hospitalized with stroke[J]. J Stroke Cerebrovasc Dis, 2013, 22(7):1146-1150.
[25] Singhal A B, Topcuoglu M A, Buonanno F S. Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusion-weighted magnetic resonance imaging study[J]. Stroke, 2002, 33(5):1267-1273.
[26] Kim S G, Hong J M, Kim H Y, et al. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea[J]. Stroke, 2010, 41(4):798-801.
[27] Mochmann H C, Scheitz J F, Petzold G C, et al. Coronary angiographic findings in acute ischemic stroke patients with elevated cardiac troponin: The Troponin Elevation in Acute Ischemic Stroke (TRELAS) Study[J]. Circulation, 2016, 133(13):1264-1271.
[28] Thålin C, Demers M, Blomgren B, et al. NETosis promotes cancer-associated arterial microthrombosis presenting as ischemic stroke with troponin elevation[J]. Thromb Res, 2016, 139:56-64.
[29] Khorana A A, Dalal M, Lin J, et al. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States[J]. Cancer, 2013, 119(3):648-655.
[30] Thompson C M, Rodgers L R. Analysis of the autopsy records of 157 cases of carcinoma of the pancreas with particular reference to the incidence of thromboembolism[J]. Am J Med Sci, 1952, 223(5):469-478.
[31] Iguchi Y, Kimura K, Kobayashi K, et al. Ischaemic stroke with malignancy may often be caused by paradoxical embolism[J]. J Neurol Neurosurg Psychiatry, 2006, 77(12):1336-1339.
[32] Umemura T, Yamamoto J, Akiba D, et al. Bilateral cerebral embolism as a characteristic feature of patients with Trousseau syndrome[J]. J Clin Neurosci, 2017, 42:155-159.
[33] Ito S, Ueda A, Murate K, et al. Differentiation of cancer from atrial fibrillation in patients with acute multifocal stroke[J]. J Neurol Sci, 2016, 368:344-348.
[34] Jovin T G, Boosupalli V, Zivkovic S A, et al. High titers of CA-125 may be associated with recurrent ischemic strokes in patients with cancer[J]. Neurology, 2005, 64(11):1944-1945.
[35] Gon Y, Sakaguchi M, Takasugi J, et al. Plasma D-dimer levels and ischaemic lesions in multiple vascular regions can predict occult cancer in patients with cryptogenic stroke[J]. Eur J Neurol, 2017, 24(3):503-508.
[36] Navi B B, Singer S, Merkler A E, et al. Recurrent thromboembolic events after ischemic stroke in patients with cancer[J]. Neurology, 2014, 83(1):26-33.
[37] Li N. Platelets in cancer metastasis: To help the "villain" to do evil[J]. Int J Cancer, 2016, 138(9):2078-2087.
[38] Nam K W, Kim C K, Kim T J, et al. Treatment of cryptogenic stroke with active cancer with a new oral anticoagulant[J]. J Stroke Cerebrovasc Dis, 2017, 26(12):2976-2980.
[39] Navi B B, Marshall R S, Bobrow D, et al. Enoxaparin vs aspirin in patients with cancer and ischemic stroke: The TEACH pilot randomized clinical trial[J]. JAMA Neurol, 2018, 75(3):379-381.
Options
Outlines

/

〈 〉